Patients with 3 vessel coronary artery disease (CAD) have similar outcomes in the composite of death, stroke and myocardial infarction (MI) when undergoing fractional flow reserve (FFR)-guided percutaneous coronary intervention (PCI) or coronary artery bypass graft (CABG), 5-year results from the FAME-3 trial show.